ChemicalBook Chinese Germany Japanese Korean

上海百生跃生物科技有限公司 Company Information
Company Name:    bioleaper
Tel:    -
Email:    guojing@bioleaper.com
Nationality:    China
WebSite:    www.bioleaper.com/
Product List:    5616
43 44 45 46 47 48 49 50 51 52 53 54 55 56 57
Product List
Anti-CLEC4C Reference Antibody (LFB patent anti-BDCA-2)
Anti-CLEC7A Reference Antibody (Baylor patent anti-Dectin-1)
Anti-Clusterin Reference Antibody (AB-16B5)
Anti-Complement C2 Reference Antibody (ARGX-117)
Anti-Complement C3 Reference Antibody (NGM621)
Anti-Complement C5 Reference Antibody (crovalimab)
Anti-Complement C5 Reference Antibody (eculizumab)
Anti-Complement C5 Reference Antibody (lendalizumab)
Anti-Complement C5 Reference Antibody (pozelimab)
Anti-Complement C5 Reference Antibody (ravulizumab)
Anti-Complement C5 Reference Antibody (tesidolumab)
Anti-Complement C5 Reference Antibody (vilobelimab)
Anti-Complement C5aR1 Reference Antibody (avdoralimab)
Anti-Complement C5aR1 Reference Antibody (G2 patent anti-C5aR)
Anti-Complement C5aR1 Reference Antibody (G2_anti-C5aR)
Anti-Complement Factor B Reference Antibody (Genentech patent anti-Factor B)
Anti-Complement Factor D Reference Antibody (lampalizumab)
Anti-Complement Factor P / Properdin Reference Antibody (Novelmed patent anti-Properdin)
Anti-c-RET Reference Antibody (Regeneron patent anti-RET)
Anti-CRTAM / CD355 Reference Antibody (Oxford Bio patent anti-CRTAM)
Anti-CSF1 / M-CSF Reference Antibody (lacnotuzumab)
Anti-CSF1R / M-CSFR / CD115 Reference Antibody (axatilimab)
Anti-CSF1R / M-CSFR / CD115 Reference Antibody (cabiralizumab)
Anti-CSF1R / M-CSFR / CD115 Reference Antibody (emactuzumab)
Anti-CSF1R / M-CSFR / CD115 Reference Antibody (LY3022855)
Anti-CSF2 / GM-CSF Reference Antibody (gimsilumab)
Anti-CSF2 / GM-CSF Reference Antibody (lenzilumab)
Anti-CSF2 / GM-CSF Reference Antibody (namilumab)
Anti-CSF2 / GM-CSF Reference Antibody (otilimab)
Anti-CSF2 / GM-CSF Reference Antibody (plonmarlimab)
Anti-CSF2 / GM-CSF Reference Antibody (Theraclone patent anti-GM-CSF)
Anti-CSF2Ra / GM-CSFRa / CD116 Reference Antibody (mavrilimumab)
Anti-CSF2Rb / CD131 Reference Antibody (CSL311)
Anti-CSF3 / G-CSF Reference Antibody (CSL324)
Anti-CSF3R / G-CSFR Reference Antibody (CSL patent anti-G-CSFR)
Anti-CTLA-4 / CD152 Reference Antibody (Antitope patent anti-CTLA4)
Anti-CTLA-4 / CD152 Reference Antibody (ipilimumab)
Anti-CTLA-4 / CD152 Reference Antibody (nurulimab)
Anti-CTLA-4 / CD152 Reference Antibody (quavonlimab)
Anti-CTLA-4 / CD152 Reference Antibody (tremelimumab)
Anti-CTLA-4 / CD152 Reference Antibody (zalifrelimab)
Anti-CTLA-8 / IL-17a Antibody (SY18-VHH-11)
Anti-CTLA-8 / IL-17a Reference Antibody (CAT-2200)
Anti-CTLA-8 / IL-17a Reference Antibody (ixekizumab)
Anti-CTLA-8 / IL-17a Reference Antibody (netakimab)
Anti-CTLA-8 / IL-17a Reference Antibody (perakizumab)
Anti-CTLA-8 / IL-17a Reference Antibody (secukinumab)
Anti-CTLA-8 / IL-17a Reference Antibody (UCB patent anti-IL-17)
Anti-CTLA-8 / IL-17a Reference Antibody (vunakizumab)
Anti-CTSS / Cathepsin S Reference Antibody (Fsn0503h)
Anti-CX3CL1 / Fractalkine Reference Antibody (quetmolimab)
Anti-CXADR Reference Antibody (Med. Bio. Labs patent anti-CXADR)
Anti-CXC-ELR Reference Antibody (Lilly patent anti-Pan-ELR+)
Anti-CXCL10 / IP-10 Reference Antibody (eldelumab)
Anti-CXCL10 / IP-10 Reference Antibody (NI-0801)
Anti-CXCL12 / SDF1a Reference Antibody (Genentech anti-CXCL12)
Anti-CXCL4 / PF4 Reference Antibody (U.Penn. patent anti-PF4)
Anti-CXCL8 / IL-8 Reference Antibody (ABX-IL8)
Anti-CXCL8 / IL-8 Reference Antibody (Genentech patent anti-IL-8)
Anti-CXCL8 / IL-8 Reference Antibody (HuMax-IL8)
Anti-CXCL9 Reference Antibody (Novimmune patent anti-CXCL9)
Anti-CXCR3 / GPR9 / CD183 Reference Antibody (Genzyme patent anti-CXCR3)
Anti-CXCR4 / CD184 Reference Antibody (Dana-Farber patent anti-CXCR4)
Anti-CXCR4 / CD184 Reference Antibody (ulocuplumab)
Anti-CXCR5 / CD185 Reference Antibody (SAR113244)
Anti-CYR61 / CCN1 Reference Antibody (Roche patent anti-CCN1)
Anti-CLDN18.2 Reference Antibody (zolbetuximab)
Anti-CLEC12A / CD371 Reference Antibody (tepoditamab)
Anti-CLEC14A Reference Antibody (Scripps Korea patent anti-CLEC14A)
Anti-CLEC4C Reference Antibody (BIIB059)
Anti-CD7 Reference Antibody (grisnilimAb)
Anti-CD74 Reference Antibody (milatuzumab)
Anti-CD98 Reference Antibody (KHK2898)
Anti-CEACAM6 / CD66c Reference Antibody (tinurilimab)
Anti-CD69 Reference Antibody (Genefrontier patent anti-CD69)
Anti-Cdiff Toxin A Reference Antibody (actoxumab)
Anti-CEACAM5 / CEA / CD66e Reference Antibody (labetuzumab)
Anti-CD59 Reference Antibody (Mellitus patent anti-CD59)
Anti-CDH3 / P-cadherin Reference Antibody (PF-03732010)
Anti-CEACAM1 / CD66a Reference Antibody (CM-24)
Anti-CD79b Reference Antibody (iladatuzumAb)
Anti-CDCP1 / CD318 Reference Antibody (U.California patent anti-CDCP1)
Anti-CHI3L1 Reference Antibody (Brown U. patent anti-CHI3L1)
Anti-CD83 Reference Antibody (Genentech patent anti-CD83)
Anti-CEACAM5 / CEA / CD66e Reference Antibody (tusamitamab)
Anti-CD59 Reference Antibody (Quark patent anti-CD59)
Anti-CDH6 / K-Cadherin Reference Antibody (DS-6000a)
Anti-CEACAM5 / CEA / CD66e Reference Antibody (cergutuzumAb)
Anti-CD79b Reference Antibody (polatuzumab)
Anti-CDH1 / E-cadherin / CD324 Reference Antibody (Stem Centrx patent anti-Cadherin-1)
Anti-Clathrin Heavy Chain / CHC Reference Antibody (Academia Sinica patent anti-Clathrin Heavy Chain)
Anti-CD7 Reference Antibody (Persongen patent anti-CD7)
Anti-CD9 Reference Antibody (Genentech patent anti-CD9)
Anti-CEACAM6 / CD66c Reference Antibody (NEO-201)
Anti-CD6 Reference Antibody (itolizumab)
Anti-CDH6 / K-Cadherin Reference Antibody (HKT288)
Anti-CEACAM5 / CEA / CD66e Reference Antibody (Immunomedics patent anti-CEACAM5 (Class III))
Anti-CD52 Reference Antibody (gatralimab)
Anti-CDH11 / Cadherin-11 Reference Antibody (RG6125)
Anti-CEACAM1 / CD66a Reference Antibody (Chaim Sheba Med. Cntr. patent anti-CEACAM1)
43 44 45 46 47 48 49 50 51 52 53 54 55 56 57
Copyright 2007©  ChemicalBook. All rights reserved.